-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TllEf/O+0CKjQmmMxazJwABTji+X4SijlU6TI6ScTzcOpQprlK5AWbe7q9vCR6na qwcrnioZVMXxmTzYjH+MvA== 0001144204-09-051750.txt : 20091123 0001144204-09-051750.hdr.sgml : 20091123 20091006163654 ACCESSION NUMBER: 0001144204-09-051750 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 CORRESP 1 filename1.htm Unassociated Document
October 6, 2009

Via EDGAR
Securities and Exchange Commission
100 F Street, N.W.
Washington, D.C.  20549
Attention:  John Dana Brown

 
Re:
NeoStem, Inc.
Registration Statement on Form S-4
Filed October 6, 2009
File No. 333-160578


Ladies and Gentlemen:

In connection with the above-captioned Registration Statement on Form S-4, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the Company hereby requests that the effective date of the above-mentioned Registration Statement on Form S-4 be accelerated to 9 am on Wednesday, October 7, 2009, or as soon thereafter as practicable.

The Company hereby acknowledges that:

·  
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
 
·  
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
 
·  
the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
 

Very truly yours,

/s/ Catherine M. Vaczy

                                Catherine M. Vaczy
                                Vice President and General Counsel
NeoStem, Inc.
 -----END PRIVACY-ENHANCED MESSAGE-----